454 related articles for article (PubMed ID: 19515221)
1. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease.
Waanders E; van Keimpema L; Brouwer JT; van Oijen MG; Aerts R; Sweep FC; Nevens F; Drenth JP
Liver Int; 2009 Oct; 29(9):1389-95. PubMed ID: 19515221
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
Kanaan N; Goffin E; Pirson Y; Devuyst O; Hassoun Z
Am J Kidney Dis; 2010 May; 55(5):916-22. PubMed ID: 20189277
[TBL] [Abstract][Full Text] [Related]
3. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
[TBL] [Abstract][Full Text] [Related]
4. Benign epithelial cyst of the spleen with a high production of carbohydrate antigen 19-9.
Ishibashi R; Sakai T; Yamashita Y; Maekawa T; Hideshima T; Shirakusa T
Int Surg; 1999; 84(2):151-4. PubMed ID: 10408287
[TBL] [Abstract][Full Text] [Related]
5. Multiple epithelial cysts of the spleen and on the splenic capsule, and high serum levels of CA19-9, CA125 and soluble IL-2 receptor.
Hashimoto T; Sugino T; Fukuda T; Hoshi N; Ogura G; Watanabe K; Satoh Y; Hasegawa T; Ohishi A; Haga J; Miyata M; Suzuki T
Pathol Int; 2004 May; 54(5):349-54. PubMed ID: 15086840
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease.
Fukasawa H; Kaneko M; Niwa H; Yasuda H; Kumagai H; Furuya R
Nephrology (Carlton); 2018 Mar; 23(3):210-216. PubMed ID: 28024168
[TBL] [Abstract][Full Text] [Related]
7. Infected hepatic cyst.
Yoshida H; Onda M; Tajiri T; Mamada Y; Taniai N; Mineta S; Hirakata A; Futami R; Arima Y; Inoue M; Hatta S; Kishimoto A
Hepatogastroenterology; 2003; 50(50):507-9. PubMed ID: 12749258
[TBL] [Abstract][Full Text] [Related]
8. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
[TBL] [Abstract][Full Text] [Related]
9. Hepatocystin is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients.
Waanders E; Lameris AL; Op den Camp HJ; Pluk W; Gloerich J; Strijk SP; Drenth JP
J Proteome Res; 2008 Jun; 7(6):2490-5. PubMed ID: 18419150
[TBL] [Abstract][Full Text] [Related]
10. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
Mann DV; Edwards R; Ho S; Lau WY; Glazer G
Eur J Surg Oncol; 2000 Aug; 26(5):474-9. PubMed ID: 11016469
[TBL] [Abstract][Full Text] [Related]
11. [A case of hydronephrosis with high level of serum Span-1 antigen and CA19-9].
Kondoh K; Noguchi S; Shuin T; Masuda M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Jan; 42(1):51-3. PubMed ID: 8686585
[TBL] [Abstract][Full Text] [Related]
12. Esophageal cyst producing CA19-9 and CA125.
Goto T; Maeshima A; Oyamada Y; Kato R
Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):448-50. PubMed ID: 20008896
[TBL] [Abstract][Full Text] [Related]
13. Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma.
Wu H; Yan LN; Cheng NS; Zhang YG; Ker CG
Hepatogastroenterology; 2007; 54(79):1915-8. PubMed ID: 18251127
[TBL] [Abstract][Full Text] [Related]
14. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
15. Use of cyst fluid CEA, CA19-9, and amylase for evaluation of pancreatic lesions.
Snozek CL; Mascarenhas RC; O'Kane DJ
Clin Biochem; 2009 Oct; 42(15):1585-8. PubMed ID: 19576876
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of both carbohydrate antigen 19-9 and duke pancreatic monoclonal antigen type 2 reflect postoperative prognosis in patients with pancreatic carcinoma.
Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
Pancreas; 2009 Aug; 38(6):619-24. PubMed ID: 19436235
[TBL] [Abstract][Full Text] [Related]
17. A simple hepatic cyst with elevated serum and cyst fluid CA19-9 levels: a case report.
Yanai H; Tada N
J Med Case Rep; 2008 Oct; 2():329. PubMed ID: 18851758
[TBL] [Abstract][Full Text] [Related]
18. Chemical analysis of adnexal cyst fluid.
Parker MF; Conslato SS; Chang AS; Taylor RR; Reed ME; Mayer AR
Gynecol Oncol; 1999 Apr; 73(1):16-20. PubMed ID: 10094874
[TBL] [Abstract][Full Text] [Related]
19. Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection.
Bloomston M; Bekaii-Saab TS; Kosuri K; Cowgill SM; Melvin WS; Ellison EC; Muscarella P
Pancreas; 2006 Oct; 33(3):246-9. PubMed ID: 17003645
[TBL] [Abstract][Full Text] [Related]
20. Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
Yuksel BC; Yildiz Y; Ozturk B; Berkem H; Katman U; Ozel H; Hengirmen S
Am J Surg; 2008 Apr; 195(4):452-6. PubMed ID: 18083135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
